Cari
Produk
Komunitas
Pasar
Berita
Broker
Lebih lanjut
ID
Mulai
Ocugen, Inc.
Pembelian
25 Mar 2024
OCGN pumps on dismissal of investor lawsuit LONG
7
Ambil chart ini
Ambil chart ini
1
1
OCGN has been a great swing trade after buying bad news. The good news has replaced the
bad. Earnings are in three days. Price well below ATH. November earnings were a beat
meaning this risky Med Tech penny stock had a lower cash burn than projected. Now
legal costs will disappear. Going long with a decent position expecting a better earnings.
In law, the Latin phrase res ipsa loquitur is sometimes used. Here it aptly applies to
Ocugen.
AwesomeAvani
Ikuti
Beyond Technical Analysis
ESPR
Growth
medtechnanocaps
medtechstocks
newstrading
NNOX
OCGN
pennystocks
preearningsplay
Value
AwesomeAvani
Ikuti
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di
Persyaratan Penggunaan
.